Skip to content

Effects of Biocidin on Oral Biofilms

Prospective Human Study Evaluating the Effects of Biocidin Liquid on Oral Biofilms: An Open-label Pilot Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07408245
Enrollment
50
Registered
2026-02-13
Start date
2026-02-17
Completion date
2026-05-30
Last updated
2026-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biofilm

Brief summary

The primary purpose of this study is to evaluate the effects of Biocidin liquid on oral biofilms among healthy adults. A single-arm, open-label prospective study will be conducted evaluating the impact of two weeks of supplementation with label dosing of Biocidin liquid on oral biofilms as assessed by SimplyPERIO (Spectrum Solutions, Salt Lake City, UT).

Interventions

DIETARY_SUPPLEMENTBiocidin Liquid

Broad-spectrum botanical liquid formula

Sponsors

OvationLab
Lead SponsorNETWORK

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Adult females or males age ≥ 25 years 2. Ability to read and speak English 3. Willingness to take use oral Biocidin as directed for two weeks 4. Willingness not to change any other oral health practices for two weeks 5. Willingness not to change dietary habits for two weeks 6. Willingness to perform a SimplyPERIO oral microbiome test before and after the two-week Biocidin intervention

Exclusion criteria

1. Current use of oral Biocidin or botanical mouthwash 2. Use of antibiotics within the past 30 days 3. Current use of fixed intraoral orthodontic appliances (e.g., dental braces, fixed retainers, or similar devices) 4. Known allergies to any of the ingredients in the product 5. Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks 6. Participants unable to provide consent

Design outcomes

Primary

MeasureTime frameDescription
Oral Biofilm MicroorganismsMeasured at baseline and conclusion of 2-week studySimplyPERIO - Oral biofilm microorganism test results are categorized as "low", "medium", and "high".

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 30, 2026